Skip to content

Ethadione

NERVOUS SYSTEM

Also known as: aethadion, didione, dimedion, dimedione, ethadionum, petidion

ATC N03AC03

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Ethadione is a drug catalogued in DrugCentral. Recorded indications include Absence seizure and Epilepsy.

  • Indications: Absence seizure and Epilepsy.
  • ATC code: N03AC03 (Oxazolidine derivatives).
  • Molecular formula: C7H11NO3; molecular weight 157.17 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Absence seizure
  • Epilepsy

Contraindications (15)

  • Acute nephropathy
  • Disease of liver
  • Disorder of optic nerve
  • Eaton-Lambert syndrome
  • Hepatic failure
  • Kidney disease
  • Leukopenia
  • Lupus erythematosus and erythema multiforme-like syndrome
  • Lymphadenopathy
  • Neutropenic disorder
  • Porphyria
  • Pregnancy, function
  • Proteinuria
  • Retinal disorder
  • Thrombocytopenic disorder

ATC classification

ATC codeTherapeutic hierarchy
N03AC03NERVOUS SYSTEM › ANTIEPILEPTICS › ANTIEPILEPTICS › Oxazolidine derivatives

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Ethadione is on its molecule page.

Molecular formulaC7H11NO3
Molecular weight157.17 g/mol
CAS number520-77-4
InChIKeySIGSNYAYBSJATD-UHFFFAOYSA-N
PubChem CID10630
CCN1C(=O)OC(C)(C)C1=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Ethadione used for?

DrugCentral lists the following indications for Ethadione: Absence seizure and Epilepsy.

What is the chemical formula of Ethadione?

Ethadione has the molecular formula C7H11NO3 and a molecular weight of 157.17 g/mol.

Browse: all drugs starting with E · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets0
Indications2
FormulaC7H11NO3
DrugCentral ID1072
Interactive profile